Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients at Risk of Acute Respiratory Failure”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableActive Not RecruitingNCT07164586
What this trial is testing

Early Detection of Acute Respiratory Failure Using an Intelligent Respiratory Monitoring System

Who this might be right for
Patients at Risk of Acute Respiratory Failure
University of Pernambuco 300
Large-scale testing (Phase 3)Ended earlyNCT04393038
What this trial is testing

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

Who this might be right for
COVID-19
Abivax S.A. 509
Not applicableStudy completedNCT02983812
What this trial is testing

Developing Enhanced Prediction Models

Who this might be right for
Acute Myocardial Infraction or Chest PainChronic Obstructive Pulmonary Disease (COPD)Congestive Heart Failure (CHF)+2 more
University of Pennsylvania 500
Not applicableEnded earlyNCT04131660
What this trial is testing

Efficacy of Volume Ventilation in Patients With Acute Respiratory Failure at Risk of Obstructive Apneas or Obesity Hypoventilation

Who this might be right for
Acute Respiratory FailureHypercapnic Respiratory FailureRespiratory Acidosis+3 more
University Hospital, Rouen 14
Not applicableStudy completedNCT00404430
What this trial is testing

Protocol Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAcute Respiratory Failure
University Hospital, Grenoble 121
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableStudy completedNCT00987740
What this trial is testing

Feasibility Study of the Hemolung Respiratory Assist System

Who this might be right for
Hypercapnic Respiratory Failure, COPD
Alung Technologies 2
Testing effectiveness (Phase 2)Ended earlyNCT02370095
What this trial is testing

Treprostinil Sodium Inhalation for Patients At High Risk for ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
University of North Carolina, Chapel Hill 14
Not applicableWithdrawnNCT00813371
What this trial is testing

Airway Pressure Release Ventilation as a Preventative Strategy

Who this might be right for
Acute Respiratory Distress SyndromeAcute Lung InjuryRespiratory Failure+1 more
Texas Tech University Health Sciences Center